SCHEMBL397417

SCHEMBL397417

CCCC(O)CCCCO

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.46
FFAR4 Q5NUL3 1/20 0.43
FFAR1 O14842 1/20 0.43
PSMD14 O00487 2/20 0.42
PLA2G1B P04054 2/20 0.42
MMP2 P08253 2/20 0.42
ATG4B Q9Y4P1 2/20 0.42
HSP90AA1 P07900 1/20 0.42
RAD52 P43351 1/20 0.42
NFKB1 P19838 1/20 0.42
GPR84 Q9NQS5 5/20 0.41
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628591 1.00 SMN1; SMN2 (0.48) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL19206170 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL554201 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
Hydrochloric Acid SCHEMBL7218925 0.97 SMN1; SMN2 (0.46) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL12491699 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL2769803 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL12491551 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL12491604 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL19206235 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1
SCHEMBL19206259 0.97 LMNA (0.50) SMN1; SMN2LMNAALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2025-02-06 US claimed
EP-4451875-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2024-10-30 EP claimed
WO-2023122003-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2023-06-29 WO claimed
US-20230147032-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS HERAEUS EPURIO GMBH (DE) 2023-05-11 US claimed
CN-111087780-B Modified polycarbonate/aliphatic aromatic copolyester composition, preparation method and application 中国石油化工股份有限公司 2022-06-28 CN claimed
CN-111100272-B Method for synthesizing biodegradable aliphatic aromatic copolyester 中国石油化工股份有限公司 2021-11-30 CN claimed
CN-111100270-B Method for preparing biodegradable aliphatic aromatic copolyester 中国石油化工股份有限公司 2021-11-30 CN claimed
WO-2021198214-A2 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co. KG (DE) 2021-10-07 WO claimed
EP-3889980-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co KG (DE) 2021-10-06 EP claimed
EP-3263578-B1 METHOD FOR PREPARING XYLULOSE FROM BIOMASS CONTAINING XYLOSE USING BUTANOL, AND METHOD FOR SEPARATING THE SAME KOREA RES INST CHEMICAL TECH (KR) 2021-08-18 EP claimed
WO-2001090285-A1 A FABRIC SOFTENING COMPOSITION COMPRISING A MALODOR CONTROLLING AGENT THE PROCTER & GAMBLE COMPANY (US) 2001-11-29 WO claimed
EP-1153119-A1 FABRIC ENHANCEMENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-11-14 EP claimed
US-6268332-B1 PRINCIPAL SOLVENT HAVING A CLOGP OF FROM ABOUT 0.15 TO ABOUT 1; POLYOXYALKYLENE ALKYL AMIDE SURFACE ACTIVE AGENT THE PROCTER & GAMBLE COMPANY 2001-07-31 US claimed
EP-1114134-A1 RINSE-ADDED FABRIC CARE COMPOSITIONS COMPRISING LOW MOLECULAR WEIGHT LINEAR AND CYCLIC POLYAMINES THE PROCTER & GAMBLE COMPANY (US) 2001-07-11 EP claimed
EP-1034240-A1 LOW SOLVENT RINSE-ADDED FABRIC SOFTENERS HAVING INCREASED SOFTNESS BENEFITS THE PROCTER & GAMBLE COMPANY (US) 2000-09-13 EP claimed
WO-2000049125-A1 FABRIC ENHANCEMENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-08-24 WO claimed
WO-2000049123-A1 FABRIC ENHANCEMENT COMPOSITIONS COMPRISING HIGH MOLECULAR WEIGHT POLYAMINES THE PROCTER & GAMBLE COMPANY (US) 2000-08-24 WO claimed
WO-2000015745-A1 RINSE-ADDED FABRIC CARE COMPOSITIONS COMPRISING LOW MOLECULAR WEIGHT LINEAR AND CYCLIC POLYAMINES THE PROCTER & GAMBLE COMPANY (US) 2000-03-23 WO claimed
WO-1999027046-A1 LOW SOLVENT RINSE-ADDED FABRIC SOFTENERS HAVING INCREASED SOFTNESS BENEFITS THE PROCTER & GAMBLE COMPANY (US) 1999-06-03 WO claimed
EP-0170466-B1 METHOD AND TEST KIT FOR DETERMINATION OF ALKALINITY IN OILS MOBIL OIL CORPORATION (US) 1988-12-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF RASGRP3, RSU1, RPP30 SMN1; SMN2 3460/4885LMNA 2815/4885ALDH1A1 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.